Hon Hai Precision Industry Co (鴻海精密) has invested in local cell-tissue banking and cell therapy company Bionet Corp (訊聯生物科技) through the purchase of NT$100 million (US$2.86 million) in Bionet shares, a Bionet official said.
The purchased shares represent 8.6 percent of Bionet’s outstanding shares, Bionet chairman Chris Tsai (蔡政憲) said at a media briefing yesterday.
The two companies plan to invest an additional NT$200 million in a joint venture called Conn Lian (康聯生醫), aimed at developing next-generation health care focused on predictive, preventive, personalized and participatory medicine, Tsai said.
Bolstered by the announcement, Bionet stocks rose limit-up to NT$43.40 on the GRETAI Securities Market. Hon Hai shares rose 5.01 percent to NT$75.5 on the Taiwan Stock Exchange.
Hon Hai’s latest announcement followed the signing on Wednesday of a global GreenCert agreement with IBM, Enterprise Information Management Inc and C-Lock Technology Inc. The companies will jointly introduce greenhouse gas emission measurement technology.
“Hon Hai will take 50 percent ownership of the newly formed company, while Bionet and the rest of the investment consortium will each take 22.5 percent and 27.5 percent,” Tsai said.
Tsai said that in order for Bionet to increase its scale of operations, it urgently needed sizable funding and a partner who understands the importance of biotechnology.
Bionet therefore approached Hon Hai as a first choice investment partner roughly one year ago, Tsai said.
“After consulting with numerous international biotechnology firms, Hon Hai has chosen to invest in Bionet due to its superior technology management and operational capabilities. This collaboration marks the nation’s first real step by a large conglomerate to actively invest in genetic engineering and stem cell research,” David Wu (吳啟誠), head of Hon Hai medical group, said at the same briefing.
In separate news, Wu said Hon Hai chairman Terry Gou (郭台銘) and his wife were both well and anticipated the arrival of their first baby sometime in May.
CHIP RACE: Three years of overbroad export controls drove foreign competitors to pursue their own AI chips, and ‘cost US taxpayers billions of dollars,’ Nvidia said China has figured out the US strategy for allowing it to buy Nvidia Corp’s H200s and is rejecting the artificial intelligence (AI) chip in favor of domestically developed semiconductors, White House AI adviser David Sacks said, citing news reports. US President Donald Trump on Monday said that he would allow shipments of Nvidia’s H200 chips to China, part of an administration effort backed by Sacks to challenge Chinese tech champions such as Huawei Technologies Co (華為) by bringing US competition to their home market. On Friday, Sacks signaled that he was uncertain about whether that approach would work. “They’re rejecting our chips,” Sacks
Taiwan’s exports soared 56 percent year-on-year to an all-time high of US$64.05 billion last month, propelled by surging global demand for artificial intelligence (AI), high-performance computing and cloud service infrastructure, the Ministry of Finance said yesterday. Department of Statistics Director-General Beatrice Tsai (蔡美娜) called the figure an unexpected upside surprise, citing a wave of technology orders from overseas customers alongside the usual year-end shopping season for technology products. Growth is likely to remain strong this month, she said, projecting a 40 percent to 45 percent expansion on an annual basis. The outperformance could prompt the Directorate-General of Budget, Accounting and
NATIONAL SECURITY: Intel’s testing of ACM tools despite US government control ‘highlights egregious gaps in US technology protection policies,’ a former official said Chipmaker Intel Corp has tested chipmaking tools this year from a toolmaker with deep roots in China and two overseas units that were targeted by US sanctions, according to two sources with direct knowledge of the matter. Intel, which fended off calls for its CEO’s resignation from US President Donald Trump in August over his alleged ties to China, got the tools from ACM Research Inc, a Fremont, California-based producer of chipmaking equipment. Two of ACM’s units, based in Shanghai and South Korea, were among a number of firms barred last year from receiving US technology over claims they have
BARRIERS: Gudeng’s chairman said it was unlikely that the US could replicate Taiwan’s science parks in Arizona, given its strict immigration policies and cultural differences Gudeng Precision Industrial Co (家登), which supplies wafer pods to the world’s major semiconductor firms, yesterday said it is in no rush to set up production in the US due to high costs. The company supplies its customers through a warehouse in Arizona jointly operated by TSS Holdings Ltd (德鑫控股), a joint holding of Gudeng and 17 Taiwanese firms in the semiconductor supply chain, including specialty plastic compounds producer Nytex Composites Co (耐特) and automated material handling system supplier Symtek Automation Asia Co (迅得). While the company has long been exploring the feasibility of setting up production in the US to address
RSS